Related references
Note: Only part of the references are listed.Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation
Linhui Wu et al.
CELL DEATH & DISEASE (2022)
Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy
Jinxin Liu et al.
SEMINARS IN CANCER BIOLOGY (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Knockdown of FBXO22 inhibits melanoma cell migration, invasion and angiogenesis via the HIF-1α/VEGF pathway
Yufan Zheng et al.
INVESTIGATIONAL NEW DRUGS (2020)
Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
Renjie Wang et al.
CANCER LETTERS (2020)
Emerging roles of F-box proteins in cancer drug resistance
Linzhi Yan et al.
DRUG RESISTANCE UPDATES (2020)
FBXO22 degrades nuclear PTEN to promote tumorigenesis
Meng-Kai Ge et al.
NATURE COMMUNICATIONS (2020)
Emerging role of FBXO22 in carcinogenesis
Jiangting Cheng et al.
CELL DEATH DISCOVERY (2020)
Leonurine Promotes Cisplatin Sensitivity in Human Cervical Cancer Cells Through Increasing Apoptosis and Inhibiting Drug-Resistant Proteins
Min Lin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2020)
Up-regulation of peroxiredoxin-1 promotes cell proliferation and metastasis and inhibits apoptosis in cervical cancer
Ermei Lu et al.
JOURNAL OF CANCER (2020)
LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57
Guohua Zhang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21
Long Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
SCFFBXO22 targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis
Jin Bai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Emerging role of F-box proteins in the regulation of epithelial-mesenchymal transition and stem cells in human cancers
Yizuo Song et al.
STEM CELL RESEARCH & THERAPY (2019)
Nrf2 Activation Promotes Lung Cancer Metastasis by Inhibiting the Degradation of Bach1
Luca Lignitto et al.
CELL (2019)
FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth
Xiao-Na Zhu et al.
CELL DEATH & DISEASE (2019)
Regulation of F-box proteins by noncoding RNAs in human cancers
Min Lin et al.
CANCER LETTERS (2019)
FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis
Feng Guo et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
FBXO22 Possesses Both Protumorigenic and Antimetastatic Roles in Breast Cancer Progression
Rui Sun et al.
CANCER RESEARCH (2018)
Ubiquitination: Friend and foe in cancer
Mohammed A. Mansour
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2018)
Ubiquitin ligases in oncogenic transformation and cancer therapy
Daniela Senft et al.
NATURE REVIEWS CANCER (2018)
F-Box Protein FBXO22 Mediates Polyubiquitination and Degradation of CD147 to Reverse Cisplatin Resistance of Tumor Cells
Bo Wu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
KLF15 Inhibits Cell Proliferation in Gastric Cancer Cells via Up-Regulating CDKN1A/p21 and CDKN1C/p57 Expression
Chongqi Sun et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Down-Regulation of the Cyclin-Dependent Kinase Inhibitor p57 Is Mediated by Jab1/Csn5 in Hepatocarcinogenesis
Hui Guo et al.
HEPATOLOGY (2016)
F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression
Xin Tian et al.
ONCOTARGET (2015)
p57Kip2 and Cancer: Time for a Critical Appraisal
Adriana Borriello et al.
MOLECULAR CANCER RESEARCH (2011)
A population-based gene signature is predictive of breast cancer survival and chemoresponse
Shruti Rathnagiriswaran et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Intracellular protein degradation: from a vague idea thru the lysosome and the ubiquitin-proteasome system and onto human diseases and drug targeting
A Ciechanover
CELL DEATH AND DIFFERENTIATION (2005)
Share Paper
